Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine

Yamei Xu¹  Xiaotong Cui¹  Hao Jiang²  Beijian Zhang²  Wei Luo²  Xinyu Weng²  Aijun Sun³  Junbo Ge³  Yun Wang⁴  Yuhong Zhao⁵ 

[1] Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China;Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China;Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, China;Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Shanghai, China;Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China;Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, China;Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Shanghai, China;Institutes of Biomedical Sciences, Fudan University, Shanghai, China;Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China;Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, China;Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Shanghai, China;Tianshan Hospital of Traditional Chinese Medicine, Shanghai, China;Tianshan Hospital of Traditional Chinese Medicine, Shanghai, China;

关键词: heart failure with preserved ejection fraction;    N6-methyladenosine;    epitranscriptomics;    METTL3;    FTO;   

DOI  :  10.3389/fcvm.2021.647806

来源: Frontiers

【 授权许可】

CC BY